Terbutaline sulphate + Bromhexine hydrochloride + GuaiphenesinThird Party Manufacturing in India

Terbutaline sulphate + Bromhexine hydrochloride + Guaiphenesin works by utilizing a three-part mechanism to improve respiratory airflow and clear mucus. Terbutaline sulphate acts as a selective beta-2 adrenergic receptor agonist to relax bronchial smooth muscle, bromhexine hydrochloride acts as a mucolytic agent to break down mucopolysaccharide fibers in thick sputum, and guaifenesin acts as an expectorant to increase respiratory tract fluid volume and reduce mucus viscosity. Unlike standard cough suppressants, this combination helps clear congested airways naturally. It is highly effective and well-tolerated for productive cough management.

Therapeutic Uses

• Bronchial Asthma: Relieves bronchospasm while thinning thick mucus plugs in acute or chronic asthmatic conditions.
• Chronic Bronchitis: Decreases sputum viscosity and improves lung airflow in long-term bronchial inflammation.
• COPD Exacerbation: Assists in thinning and expelling dense mucus plugs during obstructive airway conditions.

Why Manufacturers Choose Terbutaline sulphate + Bromhexine hydrochloride + Guaiphenesin

This combination is highly valued by pulmonologists and primary care physicians for treating chest congestion, driving strong seasonal and year-round volume. Selecting Terbutaline sulphate + Bromhexine hydrochloride + Guaiphenesin third party manufacturing in India through Celesta ensures precise blending and tableting of multi-class active ingredients. Our manufacturing partners process verified CAS 23031-32-5 core components within certified WHO-GMP environments. Utilizing these certified WHO-GMP workflows ensures exact dose uniformity and excellent stability across all tablet strengths.